RAC 1.20% $1.68 race oncology ltd

Ann: Zantrene Improves Immune Therapy Treatment of Melanoma, page-43

  1. 7,038 Posts.
    lightbulb Created with Sketch. 1793
    As Dr.T has said before Price Sensitive Ann’s have to be released when the mgmt receives them and not timed based on mgmt’s discretion either with today’s conference or tomorrow’s buyback. Otherwise mgmt would be in violation of ASX rules.

    If patent filing was the holdup and the same was completed mgmt had to take the next logical step of releasing the news. To suggest that the mgmt “timed” the Ann is untrue.

    IMO…
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.68
Change
0.020(1.20%)
Mkt cap ! $286.2M
Open High Low Value Volume
$1.68 $1.68 $1.61 $177.8K 108.9K

Buyers (Bids)

No. Vol. Price($)
1 1100 $1.64
 

Sellers (Offers)

Price($) Vol. No.
$1.68 4999 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.